Inventor · disambiguated record
Hans-Juergen Krause
Also filed as: KRAUSE HANS-JUERGEN
33 granted patents·14 pending applications·1,178 citations·filing 2002–2022
98Inventor score
Files withABBVIE BIOTECHNOLOGY LTD34ABBVIE INC3BORHANI DAVID W3ABBOTT BIOTECH LTD2ABBVIE BIOTENCHOLOGY LTD1
Top patents by PatentIndex Score
47 records- 0199US9114166B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 25, 2015·67 cites·30 claims
- 0299US8916157B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·91 cites·30 claims
- 0398US9738714B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 22, 2017·22 cites·30 claims
- 0498US9272041B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·30 cites·30 claims
- 0598US8940305B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jan 27, 2015·27 cites·30 claims
- 0698US8916158B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·31 cites·30 claims
- 0798US8911741B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 16, 2014·26 cites·30 claims
- 0898US8802101B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 12, 2014·35 cites·29 claims
- 0998US8795670B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 5, 2014·27 cites·29 claims
- 1098US8034906B2Crystalline anti-hTNFalpha antibodiesABBOTT BIOTECH LTD·Filed 2007·Granted Oct 11, 2011·105 cites·26 claims
- 1197US9327032B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted May 3, 2016·17 cites·30 claims
- 1297US9302011B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Apr 5, 2016·17 cites·30 claims
- 1397US9295725B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 29, 2016·17 cites·30 claims
- 1497US9289497B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 22, 2016·17 cites·30 claims
- 1597US9272042B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·17 cites·30 claims
- 1697US9220781B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Dec 29, 2015·19 cites·30 claims
- 1797US9085619B2Anti-TNF antibody formulationsABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 21, 2015·83 cites·30 claims
- 1897US8802102B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 12, 2014·26 cites·29 claims
- 1996US9750808B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Sep 5, 2017·10 cites·30 claims
- 2096US8883146B2Protein formulations and methods of making sameABBVIE INC·Filed 2013·Granted Nov 11, 2014·102 cites·18 claims
- 2196US8802100B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTENCHOLOGY LTD·Filed 2013·Granted Aug 12, 2014·65 cites·29 claims
- 2296US8436149B2Crystalline anti-hTNFalpha antibodiesBORHANI DAVID W·Filed 2011·Granted May 7, 2013·87 cites·27 claims
- 2395US9950066B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Apr 24, 2018·8 cites·20 claims
- 2495US9732152B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 15, 2017·8 cites·30 claims
- 2595US8932591B2Formulation of human antibodies for treating TNF-α associated disordersKRAUSE HANS-JUERGEN·Filed 2012·Granted Jan 13, 2015·30 cites·48 claims
- 2695US8420081B2Antibody formulations and methods of making sameFRAUNHOFER WOLFGANG·Filed 2008·Granted Apr 16, 2013·165 cites·135 claims
- 2792US8168760B2Crystalline anti-human IL-12 antibodiesBORHANI DAVID W·Filed 2008·Granted May 1, 2012·22 cites·45 claims
- 2882US2022241415A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 2979US2021113694A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 3078US8404819B2Crystalline anti-human IL-12 antibodiesBORHANI DAVID W·Filed 2012·Granted Mar 26, 2013·3 cites·49 claims
- 3175US11191834B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Dec 7, 2021·0 cites·20 claims
- 3275US11167030B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Nov 9, 2021·0 cites·20 claims
- 3374US2018339046A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 3473US2019358322A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 3573US2019054171A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 3672US8772458B2Crystalline anti-hTNFalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Jul 8, 2014·1 cites·21 claims
- 3768US9610301B2Powdered protein compositions and methods of making sameLASSNER PETER K·Filed 2009·Granted Apr 4, 2017·3 cites·6 claims
- 3867US2017143828A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2017·Application pending·0 cites
- 3963US2015361170A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 4061US2015183863A1Crystalline anti-htnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 4161US2016222101A1Protein formulations and methods of making sameABBVIE INC·Filed 2016·Application pending·0 cites
- 4260US8940873B2Crystalline anti-human IL-12 antibodiesABBVIE INC·Filed 2013·Granted Jan 27, 2015·0 cites·19 claims
- 4358US2023007847A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2022·Application pending·0 cites
- 4458US2004033228A1Formulation of human antibodies for treating TNF-alpha associated disordersFiled 2002·Application pending·0 cites
- 4554US2014141007A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 4654US2014141008A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 4745US2010278822A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBOTT BIOTECH LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hans-Juergen Krause files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →